Nasdaq · CIK 0001177702
SAIA SAIA INC
Insider trading from SEC Form 4. Last filing Feb 20, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at SAIA INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 57Moderate | sell 3 | Batteh Matthew J Chief Financial Officer | $350k | 700 | -17% | - | |
| 28Weak | sell 3 | Benton Kelly W VP & CAO | $230k | 460 | -10% | - | |
| 46Moderate | sell 3 | EPPS DONNA E director | $174k | 350 | -19% | - | |
| 40Moderate | sell 3 | Lal Rohit EVP IT and CIO | $627k | 1,120 | -12% | - | |
| 75Notable | sell 4 | ODELL RICHARD D director | $2.0M | 3,700 | -59% | - | |
| 37Weak | sell 4 | SUGAR PATRICK D EVP Operations | $444k | 804 | -11% | - | |
| 42Moderate | sell 3 | EISNOR DI-ANN director | $184k | 375 | -7% | - |
Congressional trades
2 trades in SAIA disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Julia Letlow House · R-LA | Purchase | SAIA Saia, Inc. - Common Stock | $1,001 to $15k | Oct 23, 2024 | 447 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | SAIA Saia, Inc. - Common Stock | $1,001 to $15k | Jan 13, 2025 | 31 days after the trade |
Transactions
The last 32 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Benton Kelly W VP & CAO | MOption exercise Common Stock | +460 | $277.86 | $128k | 4,747 | Feb 20, 2025 |
| Feb 18, 2025 | Batteh Matthew J Chief Financial Officer | SOpen-market sale Common Stock | -700 | $500.09 | $350k | 3,326 | Feb 20, 2025 |
| Feb 18, 2025 | Benton Kelly W VP & CAO | SOpen-market sale Common Stock | -460 | $500.00 | $230k | 4,287 | Feb 20, 2025 |
| Feb 18, 2025 | Benton Kelly W VP & CAO | MOption exercise Stock Options (Right to Buy)derivative | -460 | $0.00 | $0 | 0 | Feb 20, 2025 |
| Feb 11, 2025 | EPPS DONNA E director | SOpen-market sale Common Stock | -350 | $496.24 | $174k | 1,534 | Feb 13, 2025 |
| Feb 7, 2025 | Batteh Matthew J Chief Financial Officer | AGrant or award Common Stock | +780 | $0.00 | $0 | 4,365 | Feb 11, 2025 |
| Feb 7, 2025 | Benton Kelly W VP & CAO | AGrant or award Common Stock | +756 | $0.00 | $0 | 4,614 | Feb 11, 2025 |
| Feb 7, 2025 | Batteh Matthew J Chief Financial Officer | FTax withholding Common Stock | -231 | $489.51 | $113k | 4,134 | Feb 11, 2025 |
| Feb 7, 2025 | Benton Kelly W VP & CAO | FTax withholding Common Stock | -224 | $489.51 | $110k | 4,390 | Feb 11, 2025 |
| Feb 7, 2025 | Batteh Matthew J Chief Financial Officer | FTax withholding Common Stock | -66 | $489.51 | $32k | 4,068 | Feb 11, 2025 |
| Feb 7, 2025 | Benton Kelly W VP & CAO | FTax withholding Common Stock | -65 | $489.51 | $32k | 4,325 | Feb 11, 2025 |
| Feb 10, 2025 | Batteh Matthew J Chief Financial Officer | FTax withholding Common Stock | -42 | $495.99 | $21k | 4,026 | Feb 11, 2025 |
| Feb 10, 2025 | Benton Kelly W VP & CAO | FTax withholding Common Stock | -38 | $495.99 | $19k | 4,287 | Feb 11, 2025 |
| Feb 5, 2025 | Benton Kelly W VP & CAO | AGrant or award Common Stock | +323 | $0.00 | $0 | 3,893 | Feb 7, 2025 |
| Feb 5, 2025 | Batteh Matthew J Chief Financial Officer | AGrant or award Common Stock | +778 | $0.00 | $0 | 3,613 | Feb 7, 2025 |
| Feb 6, 2025 | Batteh Matthew J Chief Financial Officer | FTax withholding Common Stock | -28 | $508.47 | $14k | 3,585 | Feb 7, 2025 |
| Feb 6, 2025 | Benton Kelly W VP & CAO | FTax withholding Common Stock | -35 | $508.47 | $18k | 3,858 | Feb 7, 2025 |
| Nov 21, 2024 | Lal Rohit EVP IT and CIO | MOption exercise Common Stock | +760 | $200.81 | $153k | 9,030 | Nov 25, 2024 |
| Nov 21, 2024 | Lal Rohit EVP IT and CIO | MOption exercise Common Stock | +360 | $277.86 | $100k | 9,390 | Nov 25, 2024 |
| Nov 21, 2024 | Lal Rohit EVP IT and CIO | SOpen-market sale Common Stock | -760 | $560.00 | $426k | 8,630 | Nov 25, 2024 |
| Nov 21, 2024 | Lal Rohit EVP IT and CIO | SOpen-market sale Common Stock | -360 | $560.00 | $202k | 8,270 | Nov 25, 2024 |
| Nov 21, 2024 | Lal Rohit EVP IT and CIO | MOption exercise Stock Options (Right to Buy)derivative | -360 | $0.00 | $0 | 180 | Nov 25, 2024 |
| Nov 21, 2024 | Lal Rohit EVP IT and CIO | MOption exercise Stock Options (Right to Buy)derivative | -760 | $0.00 | $0 | 0 | Nov 25, 2024 |
| Nov 8, 2024 | ODELL RICHARD D director | SOpen-market sale Common Stock | -3,700 | $547.40 | $2.0M | 2,590 | Nov 12, 2024 |
| Nov 8, 2024 | SUGAR PATRICK D EVP Operations | MOption exercise Common Stock | +377 | $200.81 | $76k | 7,048 | Nov 12, 2024 |
| Nov 8, 2024 | SUGAR PATRICK D EVP Operations | MOption exercise Common Stock | +427 | $277.86 | $119k | 7,475 | Nov 12, 2024 |
| Nov 8, 2024 | SUGAR PATRICK D EVP Operations | SOpen-market sale Common Stock | -427 | $552.82 | $236k | 7,048 | Nov 12, 2024 |
| Nov 8, 2024 | SUGAR PATRICK D EVP Operations | SOpen-market sale Common Stock | -377 | $552.82 | $208k | 6,671 | Nov 12, 2024 |
| Nov 8, 2024 | SUGAR PATRICK D EVP Operations | MOption exercise Stock Options (Right to Buy)derivative | -427 | $0.00 | $0 | 427 | Nov 12, 2024 |
| Nov 8, 2024 | SUGAR PATRICK D EVP Operations | MOption exercise Stock Options (Right to Buy)derivative | -377 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 4, 2024 | SUGAR PATRICK D EVP Operations | FTax withholding Common Stock | -466 | $486.14 | $227k | 6,671 | Nov 6, 2024 |
| Nov 1, 2024 | EISNOR DI-ANN director | SOpen-market sale Common Stock | -375 | $491.99 | $184k | 5,243 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Batteh Matthew JChief Financial Officer
- Benton Kelly WVP & CAO
- EISNOR DI-ANNdirector
- EPPS DONNA Edirector
- Lal RohitEVP IT and CIO
- ODELL RICHARD Ddirector, ceo, officer
- SUGAR PATRICK DEVP Operations
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.